Altre lingue Euglena Co., Ltd.

Azioni

2931

JP3944370000

Tempo differito Japan Exchange Altri mercati azionari 08:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
510 ^JPY	-3,04%		-6,42%	-26,83%

20/02	Le azioni giapponesi seguono gli altri titoli dell'Asia in ribasso nonostante il taglio dei tassi della Cina	MT
20/02	Euglena riduce leggermente la perdita attribuibile per il 2023 grazie alla crescita delle vendite nette	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Seiichiro Kametani agreed to acquire Hako inc. from Euglena Co., Ltd. for ¥600 million.	13/03
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut	20/02
Euglena Slightly Narrows 2023 Attributable Loss as Net Sales Grow	20/02
Zenhoren Co.,Ltd. agreed to acquire 18.93% stake in Okinawa Basketball Co., Ltd from Euglena Co., Ltd. for ¥360 million.	24/01
KAICO, Ltd. announced that it has received ¥810 million in funding from a group of investors	19/01
Euglena Co., Ltd. agreed to acquire Saticine Medical Co., Ltd.	10/01
Euglena Co., Ltd. agreed to acquire Japan Beautech Co., Ltd. from Kirei Sozo Holdings, K.K.	10/01
Euglena Co., Ltd. entered into stock transfer agreement to acquire Nayuta Co., Ltd. from Kirei Sozo Holdings, K.K. and Hiroji Yamazaki for ¥0.0 million.	10/01
Euglena Widens Attributable Loss in Nine Month	17/11
Japanese Shares Extend Gains for Sixth Straight Trading Session; Euglena Rises 3%	04/09/23
Euglena Opens Call for Chief Future Officers Under 18 Years Old	04/09/23
Euglena Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Euglena Sees Attributable Loss Fall in FY22	17/02/23
Euglena Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending Dec. 31, 2023	16/02/23
Euglena Co., Ltd. announced that it has received ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.	06/02/23
Euglena Co., Ltd. announced that it expects to receive ¥7.7999475 billion in funding from Marui Group Co., Ltd., Rohto Pharmaceutical Co.,Ltd., Mazda Motor Corporation, Dai-ichi Life Holdings, Inc.	19/01/23
Japanese shares end lower on Fed rate hike worries	15/12/22
Japan's Nikkei inch lower on worries over Fed rate hike impact	15/12/22
Italy's Eni eyes biorefinery in Malaysia with Petronas, Euglena	14/12/22
Eni : étude d'un projet de bioraffinerie en Malaisie	14/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Euglena Co., Ltd.

Azioni

2931

JP3944370000

Altre lingue

Filtri